Results 171 to 180 of about 8,153,897 (376)

A Study of the Concentration of the Antibodies in the Body Fluids of Normal and Immune Animals

, 1910
F. C. Becht, J. R. Greer
openalex   +2 more sources

THE FRACTIONATION OF CHOLESTEROL IN BODY FLUIDS BY MEANS OF SOLVENT EXTRACTION 1 [PDF]

, 1956
Sanford O. Byers, Meyer Friedman
openalex   +1 more source

Messenger RNA biomarker signatures for forensic body fluid identification revealed by targeted RNA sequencing

bioRxiv, 2018
E. Hanson, S. Ingold, C. Haas, J. Ballantyne, J. Ballantyne   +4 more
semanticscholar   +1 more source

Development of a personalized visualization and analysis tool to improve clinical care in complex multisystem diseases with application to scleroderma

Arthritis Care &Research, Accepted Article.
Background In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of a scleroderma patient's ...
Ji Soo Kim, John Scott, Lauren Fisher, Lauren N. Smith, Willie Stewart, Adrianne Woods, Rob Smithwright, Diane Koher, Parastoo Aslanbeik, Aalok B. Shah, Brad Tibbils, Samantha I. Pitts, Ayse P. Gurses, Yushi Yang, Ana‐Maria Orbai, Antony Rosen, Laura K. Hummers, Scott L. Zeger, Ami A. Shah   +18 more
wiley   +1 more source

Differentiation of epilepsy and psychogenic nonepileptic events based on body fluid characteristics. [PDF]

Epilepsia Open, 2023
Xia Y, Lai W, Li S, Wen Z, Chen L.
europepmc   +1 more source

Microbiological Determination of Free Amino-Acids in the Body Fluid of the Silkworm Larva (Bombyx mori) [PDF]

, 1955
Toshifumi Fukuda, J. KIRIMURA, Motoichi Matuda, Tomoki Suzuki   +3 more
openalex   +1 more source

Global and regional temporal changes in cross‐country inequalities of site‐specific osteoarthritis burden, 1990–2021

Arthritis Care &Research, Accepted Article.
Objective This study examined the global and regional temporal changes in cross‐country inequalities of site‐specific osteoarthritis (OA) burden from 1990 to 2021. Methods Age‐standardized years lived with disability rate for site‐specific OA across 204 countries/territories were obtained from the Global Burden of Diseases Study (GBD) 2021.
Haowei Chen, Lei Si, David J Hunter, Lei Zhang, Zhe‐Sheng Chen, Xiaomeng Wang, Vicky Duong, Zhounan Zhou, Peihua Cao, Han Cen, Su'an Tang, Tianyu Chen, Houjun Xue, Zhaohua Zhu, Changhai Ding   +14 more
wiley   +1 more source

A Review on Microbial Species for Forensic Body Fluid Identification in Healthy and Diseased Humans. [PDF]

Curr Microbiol, 2023
Dass M, Singh Y, Ghai M.
europepmc   +1 more source

THE RELATIONSHIP BETWEEN CONCENTRATION OF SULFAMERAZINE IN BODY FLUIDS AND THE RESPONSE IN TREATMENT OF MENINGOCOCCIC MENINGITIS 1 [PDF]

, 1945
John G. Reinhold, Harrison F. Flippin, Joseph J. Zimmerman, William I. Gefter, J Riddler, Lillian Pollack, Rose P. Feldman, Rita M. Fenwick   +7 more
openalex   +1 more source

Improvements in Health‐Related Quality of Life with Treat‐to‐Target Urate‐Lowering Therapy in Gout: A Post‐hoc Analysis of a Randomized Multicenter Trial

Arthritis Care &Research, Accepted Article.
Background While treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL change.
Austin Barry, Bryant R. England, Harlan Sayles, Lindsay N. Helget, Maria Androsenko, Hongsheng Wu, Kaleb Michaud, Bridget Kramer, Jeff A. Newcomb, Mary T. Brophy, Anne Davis‐Karim, Ryan Ferguson, Michael H. Pillinger, Tuhina Neogi, Paul M. Palevsky, James R. O'Dell, Ted R. Mikuls   +16 more
wiley   +1 more source